Hosseinali Khalili
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hosseinali Khalili has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Fariborz Ghaffarpasand
Research Center for Neuromodulation and Pain, Shiraz University of Medical Sciences, Shiraz, Iran
14 shared publications - Amin Niakan
Trauma Research Center, Shahid Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
12 shared publications - Shahram Paydar
Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
9 shared publications Reza Taheri
Affiliations Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
7 shared publicationsAmin Niakan
Department of Neurosurgery, Shiraz University of Medical Sciences, Shiraz, Iran
6 shared publications- Nima Derakhshan
Research Center for Neuromodulation and Pain, Shiraz University of Medical Sciences, Shiraz, Iran
5 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 9 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0353189
Complex patterns of functional change among TBI survivors from discharge to 6-month follow-up: Findings from a registry-based cohort study
Background: Functional recovery after traumatic brain injury (TBI) is heterogeneous, and reliance on single time-point outcomes may obscure meaningful post-discharge change. Objective: To identify early clinical, laboratory, and radiologic factors associated with functional change between hospital discharge and six-month follow-up using the Glasgow Outcome Scale-Extended (GOSE). Methods: In this longitudinal study, 2,948 TBI survivors aged 12 years or older admitted to a tertiary trauma center underwent GOSE assessment at discharge and six months post-discharge. Functional trajectories were classified as recovering, stable, or regressing. Multinomial logistic regression evaluated associations between early variables and functional trajectories. Analyses were additionally stratified by discharge GOSE to assess statistical effects. Results: Substantial bidirectional functional change occurred after discharge. Several variables, including age, Glasgow Coma Scale, subarachnoid or intraventricular hemorrhage, hemoglobin, and coagulation indices, were associated with both recovery and regression. Discharge GOSE strongly predicted subsequent change but increased the odds of both improvement and decline. Subgroup analyses indicated many unexpected associations reflected ceiling and floor effects and regression to the mean. Nevertheless, some predictors showed consistent directional effects: in non-severe TBI, age 40–74 years, low admission blood glucose, and higher platelet counts; and in severe TBI, age > 40 years, low admission blood glucose, pneumocephalus, and bilateral fixed pupils. Conclusions: Post-TBI functional outcomes follow complex, often unpredictable trajectories. These findings highlight limitations of static early prognostication and support a trajectory-oriented approach to post-discharge TBI care.
- 9 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0353189
Top Cited PapersOpen AccessComplex patterns of functional change among TBI survivors from discharge to 6-month follow-up: Findings from a registry-based cohort study
Background: Functional recovery after traumatic brain injury (TBI) is heterogeneous, and reliance on single time-point outcomes may obscure meaningful post-discharge change. Objective: To identify early clinical, laboratory, and radiologic factors associated with functional change between hospital discharge and six-month follow-up using the Glasgow Outcome Scale-Extended (GOSE). Methods: In this longitudinal study, 2,948 TBI survivors aged 12 years or older admitted to a tertiary trauma center underwent GOSE assessment at discharge and six months post-discharge. Functional trajectories were classified as recovering, stable, or regressing. Multinomial logistic regression evaluated associations between early variables and functional trajectories. Analyses were additionally stratified by discharge GOSE to assess statistical effects. Results: Substantial bidirectional functional change occurred after discharge. Several variables, including age, Glasgow Coma Scale, subarachnoid or intraventricular hemorrhage, hemoglobin, and coagulation indices, were associated with both recovery and regression. Discharge GOSE strongly predicted subsequent change but increased the odds of both improvement and decline. Subgroup analyses indicated many unexpected associations reflected ceiling and floor effects and regression to the mean. Nevertheless, some predictors showed consistent directional effects: in non-severe TBI, age 40–74 years, low admission blood glucose, and higher platelet counts; and in severe TBI, age > 40 years, low admission blood glucose, pneumocephalus, and bilateral fixed pupils. Conclusions: Post-TBI functional outcomes follow complex, often unpredictable trajectories. These findings highlight limitations of static early prognostication and support a trajectory-oriented approach to post-discharge TBI care.
- Open Access
- 29 December 2025
- Published by Maad Rayan Publishing Company in hormozgan medical journal
- Vol. 29 (4) , 188-194
Effectiveness of Sleep Hygiene Programs on Sleep Quality of Patients With Mild Traumatic Brain Injury: A Randomized Controlled Trial
Background: Sleep problems are common among patients with traumatic brain injury (TBI). Accordingly, this study aimed to evaluate the effectiveness of sleep hygiene programs on emotional indices in patients with mild TBI. Methods: Overall, 60 patients with TBI were selected and randomly divided into two intervention (n=30) and control (n=30) groups. Patients in the intervention group participated in face-to-face sleep hygiene programs, consisting of three individual 45-minute sessions. Then, the Pittsburgh Sleep Quality Index (PSQI) and Depression Anxiety Stress Scale (DASS) were used to assess the patients’ sleep quality, depression, anxiety, and stress at baseline and one and three months after the intervention in each group. Results: Based on the results, PSQI and DASS scores significantly decreased during the trial in the intervention group one and three months after the intervention (P<0.001), while the corresponding scores did not change in the control group. Eventually, the time and group effect of the intervention were statistically significant in the DASS. Conclusion: In general, sleep hygiene programs can improve the sleep quality of patients with TBI while reducing emotional indicators, such as depression, anxiety, and stress, in patients with mild TBI. Trial Registration: IRCT2014041917334N1
- 29 December 2025
- Published by Maad Rayan Publishing Company in hormozgan medical journal
- Vol. 29 (4) , 188-194
Open AccessEffectiveness of Sleep Hygiene Programs on Sleep Quality of Patients With Mild Traumatic Brain Injury: A Randomized Controlled Trial
Background: Sleep problems are common among patients with traumatic brain injury (TBI). Accordingly, this study aimed to evaluate the effectiveness of sleep hygiene programs on emotional indices in patients with mild TBI. Methods: Overall, 60 patients with TBI were selected and randomly divided into two intervention (n=30) and control (n=30) groups. Patients in the intervention group participated in face-to-face sleep hygiene programs, consisting of three individual 45-minute sessions. Then, the Pittsburgh Sleep Quality Index (PSQI) and Depression Anxiety Stress Scale (DASS) were used to assess the patients’ sleep quality, depression, anxiety, and stress at baseline and one and three months after the intervention in each group. Results: Based on the results, PSQI and DASS scores significantly decreased during the trial in the intervention group one and three months after the intervention (P<0.001), while the corresponding scores did not change in the control group. Eventually, the time and group effect of the intervention were statistically significant in the DASS. Conclusion: In general, sleep hygiene programs can improve the sleep quality of patients with TBI while reducing emotional indicators, such as depression, anxiety, and stress, in patients with mild TBI. Trial Registration: IRCT2014041917334N1
- 19 December 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 82
Early and late outcomes following surgical treatment of chronic subdural hematoma: a six-year retrospective cohort study
Chronic subdural hematoma (CSDH) is a common neurosurgical disease, particularly in elderly patients, with variable clinical behavior and potential recurrence. Knowing both early and late postoperative results is paramount in optimizing patient management and reducing morbidity. We retrospectively analyzed 580 adult patients with CSDH who underwent burr-hole craniostomy from 2017 to 2023. Early (≤3 months) and late (>3 months) clinical and radiological outcomes were assessed. Hematoma volume and midline shift (MLS) were quantified using Infinitt PACS, a validated semi-automated segmentation platform, with an inter-rater intraclass correlation coefficient (ICC) exceeding 0.90, by neuroradiologists blinded to clinical data. Multivariate logistic regression identified independent predictors of recurrence. The cohort’s mean age was 63.2 ± 19.2 years, with males comprising 79.8%. Postoperative imaging demonstrated substantial reductions in hematoma thickness and MLS (>88%). Recurrence rate was 7.2%. Residual postoperative hematoma thickness (Odds Ratio 1.185; p < 0.001) and MLS (OR 1.180; p = 0.015) were significant independent predictors of recurrence. Parietal burr-hole placement was associated with superior radiological outcomes compared to frontal approaches (p = 0.004). Late follow-up data underscored sustained recovery correlated with younger age and higher admission GCS scores. Integrating volumetric imaging with validated semi-automated assessment and standardized functional grading provides a robust framework for risk stratification in CSDH. Early and late postoperative evaluations reveal key predictors of recurrence and functional outcome. These findings support tailored surgical approaches complemented by vigilant postoperative follow-up to optimize patient care and reduce recurrence rates.
- 19 December 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 82
Early and late outcomes following surgical treatment of chronic subdural hematoma: a six-year retrospective cohort study
Chronic subdural hematoma (CSDH) is a common neurosurgical disease, particularly in elderly patients, with variable clinical behavior and potential recurrence. Knowing both early and late postoperative results is paramount in optimizing patient management and reducing morbidity. We retrospectively analyzed 580 adult patients with CSDH who underwent burr-hole craniostomy from 2017 to 2023. Early (≤3 months) and late (>3 months) clinical and radiological outcomes were assessed. Hematoma volume and midline shift (MLS) were quantified using Infinitt PACS, a validated semi-automated segmentation platform, with an inter-rater intraclass correlation coefficient (ICC) exceeding 0.90, by neuroradiologists blinded to clinical data. Multivariate logistic regression identified independent predictors of recurrence. The cohort’s mean age was 63.2 ± 19.2 years, with males comprising 79.8%. Postoperative imaging demonstrated substantial reductions in hematoma thickness and MLS (>88%). Recurrence rate was 7.2%. Residual postoperative hematoma thickness (Odds Ratio 1.185; p < 0.001) and MLS (OR 1.180; p = 0.015) were significant independent predictors of recurrence. Parietal burr-hole placement was associated with superior radiological outcomes compared to frontal approaches (p = 0.004). Late follow-up data underscored sustained recovery correlated with younger age and higher admission GCS scores. Integrating volumetric imaging with validated semi-automated assessment and standardized functional grading provides a robust framework for risk stratification in CSDH. Early and late postoperative evaluations reveal key predictors of recurrence and functional outcome. These findings support tailored surgical approaches complemented by vigilant postoperative follow-up to optimize patient care and reduce recurrence rates.
- 10 November 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-10
The impact of glasgow outcome scale - extended cut-point of dichotomization on factors associated with outcomes in traumatic brain injury research
This study delves into the challenges of dichotomizing Glasgow Outcome Scale Extended (GOSE) scores in Traumatic Brain Injury (TBI) research, aiming to elu
- 10 November 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-10
The impact of glasgow outcome scale - extended cut-point of dichotomization on factors associated with outcomes in traumatic brain injury research
This study delves into the challenges of dichotomizing Glasgow Outcome Scale Extended (GOSE) scores in Traumatic Brain Injury (TBI) research, aiming to elu
- 23 July 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 196 (Pt B) , 110827
A practical approach to predicting long-term outcomes in traumatic brain injury: Enhancing clinical decision-making with machine learning
- 23 July 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 196 (Pt B) , 110827
A practical approach to predicting long-term outcomes in traumatic brain injury: Enhancing clinical decision-making with machine learning
- 7 July 2025
- Published by Springer Nature in Acta Neurologica Belgica
- p. 1-9
The effect of methylphenidate and amantadine co-administration on functional outcome of patients with blunt traumatic brain injury: A randomized controlled trial
Introduction Traumatic brain injury (TBI) poses a large burden and cost on the patients, being among the most prevalent causes for emergency department visits. One of the major issues with TBI is the long-term functional outcome of patients, causing disabilities affecting the patient and the surrounding members of society. Several attempts have been made in order to address functional outcomes via means such as pharmacotherapy, physical therapy, and newer methods. In this study, we aimed to conduct a double-blinded, randomized controlled trial with the administration of methylphenidate and amantadine, two drugs proven effective separately in previous studies, to evaluate the functional outcome of patients with blunt TBI. Methods Patients with blunt TBI were randomly assigned into treatment and control groups. Patients in the treatment group received 100 mg of amantadine and 20 mg of methylphenidate twice daily while patients in the control group received similarly shaped placebos. The patients age, gender, GCS, ICU and hospital length of stay and GOSE were evaluated and calculated for evaluation of outcome and initial condition. The main target was GOSE evaluated 6 months after discharge. Results A total of 184 patients were included in our study, randomly and equally divided into the treatment and control groups. The mean age of patients was 40.63 ± 17.46, and 84.8% of patients were male. There was no significant difference between the two groups’ age, gender, and initial GCS. Regarding outcome measures, there was no statistical difference between the groups in hospital and ICU length of stay. GOSE was significantly higher in patients in the treatment group (6.22 ± 2.06 vs. 5.37 ± 2.54, p = 0.014). Conclusion Co-administering methylphenidate and amantadine could help patients with blunt TBI, especially in long-term settings, regarding their functional outcome.
- 7 July 2025
- Published by Springer Nature in Acta Neurologica Belgica
- p. 1-9
The effect of methylphenidate and amantadine co-administration on functional outcome of patients with blunt traumatic brain injury: A randomized controlled trial
Introduction Traumatic brain injury (TBI) poses a large burden and cost on the patients, being among the most prevalent causes for emergency department visits. One of the major issues with TBI is the long-term functional outcome of patients, causing disabilities affecting the patient and the surrounding members of society. Several attempts have been made in order to address functional outcomes via means such as pharmacotherapy, physical therapy, and newer methods. In this study, we aimed to conduct a double-blinded, randomized controlled trial with the administration of methylphenidate and amantadine, two drugs proven effective separately in previous studies, to evaluate the functional outcome of patients with blunt TBI. Methods Patients with blunt TBI were randomly assigned into treatment and control groups. Patients in the treatment group received 100 mg of amantadine and 20 mg of methylphenidate twice daily while patients in the control group received similarly shaped placebos. The patients age, gender, GCS, ICU and hospital length of stay and GOSE were evaluated and calculated for evaluation of outcome and initial condition. The main target was GOSE evaluated 6 months after discharge. Results A total of 184 patients were included in our study, randomly and equally divided into the treatment and control groups. The mean age of patients was 40.63 ± 17.46, and 84.8% of patients were male. There was no significant difference between the two groups’ age, gender, and initial GCS. Regarding outcome measures, there was no statistical difference between the groups in hospital and ICU length of stay. GOSE was significantly higher in patients in the treatment group (6.22 ± 2.06 vs. 5.37 ± 2.54, p = 0.014). Conclusion Co-administering methylphenidate and amantadine could help patients with blunt TBI, especially in long-term settings, regarding their functional outcome.
- 26 December 2024
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-11
Efficacy of oral modafinil on accelerating consciousness recovery in adult patients with moderate to severe acute traumatic brain injury admitted to intensive care unit: a randomized double-blind clinical trial
Background Traumatic Brain Injury (TBI) is a leading cause of hospitalization and disability in young and middle-aged adults. This study aims to survey the efficacy of oral modafinil, a low-side-effect central nervous system stimulant, in the enhancement of consciousness recovery in moderate to severe TBI patients in the ICUs of a referral trauma center. Materials and Methods All ICU patients meeting inclusion criteria between April 2021 and April 2023 were screened. Eligible patients had a motor Glasgow Coma Score(GCS) of 4 or 5 and did not receive continuous intravenous sedatives within 24 h before screening. They were randomly assigned to receive 200mg of enteral modafinil or placebo daily for 7 days. Motor GCS and total GCS scores, ICU/hospital stay duration, mechanical ventilation requirement, tracheal tube removal time, and tracheostomy needs were recorded. Results Among the included 85 eligible patients, there was no significant difference between the modafinil and placebo groups in the median days between the intervention and the time of a 2-unit increase in total GCS (P = 0.25) or a 1-unit increase in motor GCS (P-value = 0.31). The group assignment also had no impact on the mean GCS (P-value = 0.533) and mean motor GCS (P-value = 0.167) over time. The only significant difference was in the proportion of patients with an increase in total GCS by 2 units, which was 54% for the modafinil vs. 32% for the placebo group (P-value = 0.04), and an increase in motor GCS by 1 unit, with 56% in the modafinil vs. 34% in the placebo group (P-value = 0.04). Conclusion The administration of modafinil appears to be safe and beneficial for patients with severe TBI during their stay in the ICU.
- 26 December 2024
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-11
Efficacy of oral modafinil on accelerating consciousness recovery in adult patients with moderate to severe acute traumatic brain injury admitted to intensive care unit: a randomized double-blind clinical trial
Background Traumatic Brain Injury (TBI) is a leading cause of hospitalization and disability in young and middle-aged adults. This study aims to survey the efficacy of oral modafinil, a low-side-effect central nervous system stimulant, in the enhancement of consciousness recovery in moderate to severe TBI patients in the ICUs of a referral trauma center. Materials and Methods All ICU patients meeting inclusion criteria between April 2021 and April 2023 were screened. Eligible patients had a motor Glasgow Coma Score(GCS) of 4 or 5 and did not receive continuous intravenous sedatives within 24 h before screening. They were randomly assigned to receive 200mg of enteral modafinil or placebo daily for 7 days. Motor GCS and total GCS scores, ICU/hospital stay duration, mechanical ventilation requirement, tracheal tube removal time, and tracheostomy needs were recorded. Results Among the included 85 eligible patients, there was no significant difference between the modafinil and placebo groups in the median days between the intervention and the time of a 2-unit increase in total GCS (P = 0.25) or a 1-unit increase in motor GCS (P-value = 0.31). The group assignment also had no impact on the mean GCS (P-value = 0.533) and mean motor GCS (P-value = 0.167) over time. The only significant difference was in the proportion of patients with an increase in total GCS by 2 units, which was 54% for the modafinil vs. 32% for the placebo group (P-value = 0.04), and an increase in motor GCS by 1 unit, with 56% in the modafinil vs. 34% in the placebo group (P-value = 0.04). Conclusion The administration of modafinil appears to be safe and beneficial for patients with severe TBI during their stay in the ICU.
- 15 November 2024
- Published by Springer Nature in Neurosurgical Review
- Vol. 47 (1) , 1-11
Pre-admission opioid use disorder as a new predictor of in-hospital mortality and six-month outcomes in traumatic brain injury patients: a retrospective longitudinal cohort study
Background The present study aimed to investigate the effect of pre-admission Opioid Use Disorder (OUD) on in-hospital mortality and 6-month follow-up TBI outcomes. Design This study included 2804 patients with TBI admitted to the Intensive Care Unit of Emtiaz (Rajaee) Hospital, a referral trauma center in Shiraz, Iran. Finally, 1087 eligible participants were selected from included patients. Then, 872 discharged patients were followed for six months. Subsequently, unfavorable neurological outcomes (Glasgow Outcome Scale-Extended ≤ 4) and the mortality rate were compared among the patients with and without OUD. Results The mean age of the patients was 38.0 ± 18.9 years old (84.7% men). About 9.2% of patients had OUD. Opioid users had a slightly lower risk of in-hospital mortality (OR = 0.62, 95% CI = [0.328, 1.183], P-value = 0.148). In contrast, 6-month follow-up mortality significantly increased in the survived patients with a history of pre-admission OUD (OR = 2.49, 95%CI= [1.29, 2.80], P-value = 0.007). Moreover, 6-month unfavorable outcomes were raised in OUD, though it was not significant (OR = 1.59, 95%CI= [0.89, 2.84], P-value = 0.121). Conclusions Our results revealed that patients with OUD are at increased risk of 6-month follow-up complications and also death following moderate to severe TBI. Although OUD decreased in-hospital mortality, 6-month follow-up indicated that mortality and unfavorable outcomes were increased in the OUD group. Based on the existing evidence, this effect is probably not only due to the destructive impact of pre-admission OUD on brain physiology. However, it may also be due to an increase in opioid consumption to alleviate pain and withdrawal symptoms after hospital discharge.
- 15 November 2024
- Published by Springer Nature in Neurosurgical Review
- Vol. 47 (1) , 1-11
Pre-admission opioid use disorder as a new predictor of in-hospital mortality and six-month outcomes in traumatic brain injury patients: a retrospective longitudinal cohort study
Background The present study aimed to investigate the effect of pre-admission Opioid Use Disorder (OUD) on in-hospital mortality and 6-month follow-up TBI outcomes. Design This study included 2804 patients with TBI admitted to the Intensive Care Unit of Emtiaz (Rajaee) Hospital, a referral trauma center in Shiraz, Iran. Finally, 1087 eligible participants were selected from included patients. Then, 872 discharged patients were followed for six months. Subsequently, unfavorable neurological outcomes (Glasgow Outcome Scale-Extended ≤ 4) and the mortality rate were compared among the patients with and without OUD. Results The mean age of the patients was 38.0 ± 18.9 years old (84.7% men). About 9.2% of patients had OUD. Opioid users had a slightly lower risk of in-hospital mortality (OR = 0.62, 95% CI = [0.328, 1.183], P-value = 0.148). In contrast, 6-month follow-up mortality significantly increased in the survived patients with a history of pre-admission OUD (OR = 2.49, 95%CI= [1.29, 2.80], P-value = 0.007). Moreover, 6-month unfavorable outcomes were raised in OUD, though it was not significant (OR = 1.59, 95%CI= [0.89, 2.84], P-value = 0.121). Conclusions Our results revealed that patients with OUD are at increased risk of 6-month follow-up complications and also death following moderate to severe TBI. Although OUD decreased in-hospital mortality, 6-month follow-up indicated that mortality and unfavorable outcomes were increased in the OUD group. Based on the existing evidence, this effect is probably not only due to the destructive impact of pre-admission OUD on brain physiology. However, it may also be due to an increase in opioid consumption to alleviate pain and withdrawal symptoms after hospital discharge.
- 28 February 2024
- Published by Springer Nature in Neurosurgical Review
- Vol. 47 (1) , 1-8
Effect of low fibrinogen level on in-hospital mortality and 6-month functional outcome of TBI patients, a single center experience
In patients affected by traumatic brain injury (TBI), hypofibrinogenemia within the initial hours of trauma can be expected due to vascular and inflammatory changes. In this study, we aimed to evaluate the effect of hypofibrinogenemia on the in-hospital mortality and 6-month functional outcomes of TBI patients, admitted to Rajaee Hospital, a referral trauma center in Shiraz, Iran. This study included all TBI patients admitted to our center who had no prior history of coagulopathy or any systemic disease, were alive on arrival, and had not received any blood product before admission. On admission, hospitalization, imaging, and 6-month follow-up information of included patients were extracted from the TBI registry database. The baseline characteristics of patients with fibrinogen levels of less than 150 mg/dL were compared with the cases with higher levels. To assess the effect of low fibrinogen levels on in-hospital mortality, a uni- and multivariate was conducted between those who died in hospital and survivors. Based on the 6-month GOSE score of patients, those with GOSE < 4 (unfavorable outcome) were compared with those with a favorable outcome. A total of 3049 patients (84.3% male, 15.7% female), with a mean age of 39.25 ± 18.87, met the eligibility criteria of this study. 494 patients had fibrinogen levels < 150 mg/dl, who were mostly younger and had lower average GCS scores in comparison to cases with higher fibrinogen levels. By comparison of the patients who died during hospitalization and survivors, it was shown that fibrinogen < 150 mg/dl is among the prognostic factors for in-hospital mortality (OR:1.75, CI: 1.32:2.34, P-value < 0.001), while the comparison between patients with the favorable and unfavorable functional outcome at 6-month follow-up, was not in favor of prognostic effect of low fibrinogen level (OR: 0.80, CI: 0.58: 1.11, P-value: 0.19). Hypofibrinogenemia is associated with in-hospital mortality of TBI patients, along with known factors such as higher age and lower initial GCS score. However, it is not among the prognostic factors of midterm functional outcome.
- 28 February 2024
- Published by Springer Nature in Neurosurgical Review
- Vol. 47 (1) , 1-8
Effect of low fibrinogen level on in-hospital mortality and 6-month functional outcome of TBI patients, a single center experience
In patients affected by traumatic brain injury (TBI), hypofibrinogenemia within the initial hours of trauma can be expected due to vascular and inflammatory changes. In this study, we aimed to evaluate the effect of hypofibrinogenemia on the in-hospital mortality and 6-month functional outcomes of TBI patients, admitted to Rajaee Hospital, a referral trauma center in Shiraz, Iran. This study included all TBI patients admitted to our center who had no prior history of coagulopathy or any systemic disease, were alive on arrival, and had not received any blood product before admission. On admission, hospitalization, imaging, and 6-month follow-up information of included patients were extracted from the TBI registry database. The baseline characteristics of patients with fibrinogen levels of less than 150 mg/dL were compared with the cases with higher levels. To assess the effect of low fibrinogen levels on in-hospital mortality, a uni- and multivariate was conducted between those who died in hospital and survivors. Based on the 6-month GOSE score of patients, those with GOSE < 4 (unfavorable outcome) were compared with those with a favorable outcome. A total of 3049 patients (84.3% male, 15.7% female), with a mean age of 39.25 ± 18.87, met the eligibility criteria of this study. 494 patients had fibrinogen levels < 150 mg/dl, who were mostly younger and had lower average GCS scores in comparison to cases with higher fibrinogen levels. By comparison of the patients who died during hospitalization and survivors, it was shown that fibrinogen < 150 mg/dl is among the prognostic factors for in-hospital mortality (OR:1.75, CI: 1.32:2.34, P-value < 0.001), while the comparison between patients with the favorable and unfavorable functional outcome at 6-month follow-up, was not in favor of prognostic effect of low fibrinogen level (OR: 0.80, CI: 0.58: 1.11, P-value: 0.19). Hypofibrinogenemia is associated with in-hospital mortality of TBI patients, along with known factors such as higher age and lower initial GCS score. However, it is not among the prognostic factors of midterm functional outcome.
- 6 July 2023
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 114, 146-150
Effect of Dexmedotomdine hydrochloride (Percedex®) on functional outcome of patients with moderate and severe traumatic brain injury
- 6 July 2023
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 114, 146-150
Effect of Dexmedotomdine hydrochloride (Percedex®) on functional outcome of patients with moderate and severe traumatic brain injury